Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 3.586 Q1 | 233 | 160 | 392 | 29808 | 4172 | 392 | 9.64 | 186.30 | 40.22 | |
2 | Drug Resistance Updates | journal | 4.319 Q1 | 132 | 18 | 70 | 3179 | 983 | 70 | 12.31 | 176.61 | 41.98 | |
3 | Drug Metabolism Reviews | journal | 0.944 Q2 | 108 | 25 | 89 | 3488 | 376 | 89 | 4.15 | 139.52 | 39.08 | |
4 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 | 40.18 | |
5 | Advanced Therapeutics | journal | 39 | 53 | 0 | 5982 | 0 | 0 | 0.00 | 112.87 | 34.92 | ||
6 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q3 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | 50.97 | |
7 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | 32.58 | |
8 | Cochrane Database of Systematic Reviews | journal | 1.609 Q1 | 327 | 1109 | 4456 | 109105 | 17077 | 4430 | 3.51 | 98.38 | 48.02 | |
9 | Cancer Drug Resistance | journal | 24 | 18 | 0 | 1724 | 0 | 0 | 0.00 | 95.78 | 46.43 | ||
10 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 17 | 47 | 1568 | 78 | 43 | 2.18 | 92.24 | 39.68 | ||
11 | Neurotherapeutics | journal | 2.565 Q1 | 136 | 92 | 252 | 8483 | 1460 | 233 | 5.29 | 92.21 | 40.44 | |
12 | Current Topics in Pharmacology | journal | 0.137 Q4 | 8 | 11 | 26 | 994 | 7 | 26 | 0.13 | 90.36 | 41.03 | |
13 | Pharmacopsychiatry | journal | 0.667 Q2 | 84 | 39 | 133 | 3413 | 267 | 115 | 2.16 | 87.51 | 29.25 | |
14 | Psychopharmacology Bulletin | journal | 0.525 Q3 | 66 | 22 | 41 | 1832 | 74 | 37 | 1.80 | 83.27 | 42.65 | |
15 | Expert Review of Neurotherapeutics | journal | 1.064 Q1 | 98 | 92 | 369 | 7652 | 1176 | 325 | 3.10 | 83.17 | 31.97 | |
16 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 6 | 4 | 488 | 10 | 3 | 2.50 | 81.33 | 56.25 | ||
17 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | 37.26 | |
18 | Journal of Cardiovascular Development and Disease | journal | 32 | 63 | 73 | 4970 | 129 | 70 | 1.75 | 78.89 | 47.60 | ||
19 | Expert Review of Clinical Pharmacology | journal | 0.731 Q2 | 60 | 119 | 341 | 9352 | 901 | 316 | 2.53 | 78.59 | 35.77 | |
20 | Journal of Biomedical Science | journal | 1.611 Q1 | 110 | 90 | 283 | 6998 | 1398 | 283 | 5.40 | 77.76 | 42.55 | |
21 | Vaccines | journal | 2.136 Q1 | 85 | 81 | 150 | 6256 | 848 | 145 | 4.94 | 77.23 | 45.43 | |
22 | Expert Opinion on Orphan Drugs | journal | 0.302 Q3 | 27 | 77 | 350 | 5928 | 262 | 338 | 0.74 | 76.99 | 41.74 | |
23 | Expert Review of Anticancer Therapy | journal | 0.881 Q2 | 85 | 127 | 391 | 9577 | 886 | 353 | 2.39 | 75.41 | 35.84 | |
24 | Expert Opinion on Pharmacotherapy | journal | 0.866 Q2 | 93 | 213 | 696 | 15010 | 2012 | 652 | 2.80 | 70.47 | 34.87 | |
25 | Drugs | journal | 1.527 Q1 | 188 | 161 | 480 | 11332 | 2556 | 471 | 5.41 | 70.39 | 36.91 | |
26 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | 44.44 | |
27 | CNS Drugs | journal | 1.553 Q1 | 129 | 90 | 251 | 6083 | 1204 | 247 | 4.41 | 67.59 | 40.57 | |
28 | Side Effects of Drugs Annual | book series | 0.108 Q4 | 9 | 50 | 147 | 3307 | 77 | 3 | 0.65 | 66.14 | 0.00 | |
29 | Current Treatment Options in Oncology | journal | 1.570 Q1 | 66 | 80 | 198 | 5201 | 807 | 198 | 4.20 | 65.01 | 41.00 | |
30 | Antibiotics | journal | 1.121 Q1 | 77 | 110 | 114 | 7149 | 397 | 111 | 3.18 | 64.99 | 48.57 | |
31 | Frontiers in Pharmacology | journal | 1.256 Q1 | 154 | 1497 | 1757 | 97013 | 7210 | 1686 | 3.87 | 64.80 | 44.28 | |
32 | Paediatric Drugs | journal | 0.620 Q2 | 70 | 54 | 152 | 3443 | 323 | 145 | 1.87 | 63.76 | 47.56 | |
33 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 68 | 1462 | 74 | 55 | 0.96 | 60.92 | 31.87 | ||
34 | European Neuropsychopharmacology | journal | 1.911 Q1 | 130 | 124 | 551 | 7515 | 2478 | 529 | 4.34 | 60.60 | 41.37 | |
35 | BioDrugs | journal | 1.601 Q1 | 79 | 60 | 128 | 3632 | 663 | 124 | 5.11 | 60.53 | 36.27 | |
36 | Expert Opinion on Drug Safety | journal | 1.007 Q2 | 90 | 131 | 484 | 7888 | 1613 | 465 | 3.34 | 60.21 | 45.54 | |
37 | Anales de la Real Academia Nacional de Farmacia (discontinued) | journal | 0.159 Q3 | 10 | 22 | 136 | 1309 | 17 | 118 | 0.12 | 59.50 | 55.56 | |
38 | Current Cardiovascular Risk Reports | journal | 0.476 Q3 | 34 | 31 | 137 | 1841 | 117 | 137 | 0.72 | 59.39 | 39.13 | |
39 | Journal of Psychopharmacology | journal | 1.672 Q1 | 135 | 138 | 426 | 8170 | 1978 | 401 | 4.03 | 59.20 | 41.74 | |
40 | Therapeutic Advances in Respiratory Disease | journal | 1.020 Q2 | 50 | 38 | 118 | 2248 | 373 | 113 | 3.34 | 59.16 | 45.35 | |
41 | Targeted Oncology | journal | 1.322 Q1 | 59 | 73 | 205 | 4317 | 728 | 200 | 3.74 | 59.14 | 42.36 | |
42 | Clinical Pharmacokinetics | journal | 1.529 Q1 | 184 | 119 | 340 | 6974 | 1545 | 311 | 4.47 | 58.61 | 35.37 | |
43 | Therapeutic Advances in Psychopharmacology | journal | 43 | 32 | 122 | 1861 | 296 | 90 | 2.47 | 58.16 | 27.72 | ||
44 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | 39.33 | |
45 | Methods in Pharmacology and Toxicology | book series | 0.116 Q4 | 14 | 97 | 224 | 5578 | 72 | 62 | 0.36 | 57.51 | 0.00 | |
46 | Drugs and Aging | journal | 1.128 Q1 | 109 | 94 | 273 | 5367 | 871 | 266 | 2.92 | 57.10 | 43.10 | |
47 | Acta Pharmacologica Sinica | journal | 1.224 Q1 | 117 | 189 | 460 | 10647 | 1838 | 454 | 3.81 | 56.33 | 41.59 | |
48 | Contemporary Clinical Trials | journal | 1.478 Q1 | 75 | 208 | 533 | 11717 | 1507 | 517 | 2.44 | 56.33 | 53.88 | |
49 | PharmaNutrition | journal | 0.665 Q2 | 30 | 25 | 61 | 1397 | 168 | 60 | 3.33 | 55.88 | 43.79 | |
50 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | 46.80 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®